Acute and Post-Acute COVID-19 Severity and Mortality in Patients with Hematologic Malignancies: A Population-Based Registry Study

Introduction: The severity of acute clinical outcomes and mortality in hematologic malignancy (HM) patients infected by SARS-CoV-2 was exhaustively documented in the first weeks of the pandemic. A consistent increased mortality compared to non-cancer patients was observed across studies. In this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Lopez, Joaquin, De La Cruz, Javier, Gil-Manso, Rodrigo, Cedillo, Angel, Alegre, Adrian, Llamas Sillero, Maria Pilar, Duarte, Rafael F., Jiménez-Yuste, Víctor, Hernandez, jose Angel, Kwon, Mi, Sanchez Godoy, Pedro, Martinez-Barranco, Pilar, Colás Lahuerta, Blanca, Herrera Puente, Pilar, Benito, Lauren, Velasco, Alberto, Matilla, Arturo, Alaez, Concha, Martos, Rafael, Martínez-Chamorro, Carmen, Quiroz, Keina, del Campo, Juan F, De La Fuente, Adolfo, Herraez, Maria Regina, Pascual, Adriana, Gomez, Elvira, Perez De Oteyza, Jaime, Ruiz, Elena, Diez Martin, Jose Luis, Garcia-Suarez, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
905.Outcomes Research-Lymphoid Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701685/
http://dx.doi.org/10.1182/blood-2021-152539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701685/
http://dx.doi.org/10.1182/blood-2021-152539

Ejemplares similares